Clinical Trial Update: Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing apixaban to warfarin in patients with left ventricular thrombus is completed, evaluating anticoagulation strategy in this condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Thrombosis
• Myocardial Infarction

Drugs mentioned

• Apixaban (apixaban)
• Warfarin (warfarin)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Acute Myocardial Infarction, Left Ventricular Thrombosis | Phase 3 | Status: COMPLETED